Dexcom, Inc. (NASDAQ:DXCM) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET
Company Participants
Sean Christensen - Director, Corporate Affairs & Head of IR
Kevin Sayer - Executive Chairman, CEO & President
Jereme Sylvain - EVP, CFO & CAO
Jake Leach - EVP, Chief Operating Officer
Terry Lauver - Chief Commercial Officer
Conference Call Participants
Robert Marcus - JPMorgan Chase & Co.
Margaret Kaczor - William Blair & Company
Larry Biegelsen - Wells Fargo Securities
Danielle Antalffy - UBS
Matt Taylor - Jefferies
Matthew O'Brien - Piper Sandler & Co.
Mathew Blackman - Stifel, Nicolaus & Company
Joanne Wuensch - Citigroup
Jeff Johnson - Robert W. Baird & Co.
Travis Steed - Bank of America Merrill Lynch
Marie Thibault - BTIG
Caitlin Cronin - Cannacord Genuity
Jayson Bedford - Raymond James & Associates
Michael Polark - Wolfe research
Steve Lichtman - Oppenheimer
Josh Jennings - TD Cowen
Matt Miksic - Barclays Bank
Mike Kratky - Leerink Partners
Operator
Welcome to the Dexcom Third Quarter 2023 Earnings Release Conference Call. My name is Montieth [Ph] and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question answer session. [Operator Instructions] As a reminder, the conference is being recorded.
I will now turn the call over to Sean Christensen, Vice President of Finance and Investor Relations. Mr. Christensen, you may begin.
Sean Christensen
Thank you, operator and welcome to Dexcom's third quarter 2023 earnings call. Our agenda begins with Kevin Sayer, Dexcom's Chairman, President and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer.
Following our prepared remarks, we will open the call up for your questions. At that time, we ask analysts to limit themselves to one question so we can provide an opportunity for everyone participating today. Please note that there are also slides available related to our third quarter performance on the Dexcom Investor Relations website on the Events and Presentations page.
With that, let's review our Safe Harbor statement. Some of the statements we will make in today's call may constitute forward-looking statements. These statements reflect management's intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance. All forward-looking statements included in this presentation are made as of the date hereof based on information currently available to Dexcom are subject to various risks and uncertainties and actual results could differ materially from those anticipated in the forward-looking statements.